首页> 美国卫生研究院文献>Scientific Reports >An Injectable Enzymatically Crosslinked Carboxymethylated Pullulan/Chondroitin Sulfate Hydrogel for Cartilage Tissue Engineering
【2h】

An Injectable Enzymatically Crosslinked Carboxymethylated Pullulan/Chondroitin Sulfate Hydrogel for Cartilage Tissue Engineering

机译:用于软骨组织工程的可注射酶联交联羧甲基化支链淀粉/硫酸软骨素水凝胶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, an enzymatically cross-linked injectable and biodegradable hydrogel system comprising carboxymethyl pullulan-tyramine (CMP-TA) and chondroitin sulfate-tyramine (CS-TA) conjugates was successfully developed under physiological conditions in the presence of both horseradish peroxidase (HRP) and hydrogen peroxide (H2O2) for cartilage tissue engineering (CTTE). The HRP crosslinking method makes this injectable system feasible, minimally invasive and easily translatable for regenerative medicine applications. The physicochemical properties of the mechanically stable hydrogel system can be modulated by varying the weight ratio and concentration of polymer as well as the concentrations of crosslinking reagents. Additionally, the cellular behaviour of porcine auricular chondrocytes encapsulated into CMP-TA/CS-TA hydrogels demonstrates that the hydrogel system has a good cyto-compatibility. Specifically, compared to the CMP-TA hydrogel, these CMP-TA/CS-TA composite hydrogels have enhanced cell proliferation and increased cartilaginous ECM deposition, which significantly facilitate chondrogenesis. Furthermore, histological analysis indicates that the hydrogel system exhibits acceptable tissue compatibility by using a mouse subcutaneous implantation model. Overall, the novel injectable pullulan/chondroitin sulfate composite hydrogels presented here are expected to be useful biomaterial scaffold for regenerating cartilage tissue.
机译:在这项研究中,在两种辣根过氧化物酶(HRP)存在下,在生理条件下成功开发了一种酶促交联的可注射和可生物降解的水凝胶系统,该系统包含羧甲基支链淀粉-酪胺(CMP-TA)和硫酸软骨素-酪胺(CS-TA)结合物。 )和过氧化氢(H2O2)用于软骨组织工程(CTTE)。 HRP交联方法使该注射系统可行,微创且易于翻译,可用于再生医学应用。可以通过改变聚合物的重量比和浓度以及交联剂的浓度来调节机械稳定水凝胶体系的物理化学性质。此外,封装在CMP-TA / CS-TA水凝胶中的猪耳软骨细胞的细胞行为证明该水凝胶系统具有良好的细胞相容性。具体而言,与CMP-TA水凝胶相比,这些CMP-TA / CS-TA复合水凝胶具有增强的细胞增殖能力和增加的软骨ECM沉积能力,从而显着促进软骨形成。此外,组织学分析表明,通过使用小鼠皮下植入模型,水凝胶系统表现出可接受的组织相容性。总体而言,本文介绍的新型可注射支链淀粉/硫酸软骨素复合水凝胶有望成为再生软骨组织的有用生物材料支架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号